Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.
Androgen receptor (AR) is commonly expressed in both the epithelium of normal mammary glands and in breast cancers. AR expression in breast cancers is independent of estrogen receptor alpha (ERα) status and is frequently associated with overexpression of the ERBB2 oncogene. AR signaling effects on b...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3620158?pdf=render |
| _version_ | 1828520565270380544 |
|---|---|
| author | Myles C Hodgson Garrett Vanostran Sarah Alghamdi Robert J Poppiti Alexander I Agoulnik Irina U Agoulnik |
| author_facet | Myles C Hodgson Garrett Vanostran Sarah Alghamdi Robert J Poppiti Alexander I Agoulnik Irina U Agoulnik |
| author_sort | Myles C Hodgson |
| collection | DOAJ |
| description | Androgen receptor (AR) is commonly expressed in both the epithelium of normal mammary glands and in breast cancers. AR expression in breast cancers is independent of estrogen receptor alpha (ERα) status and is frequently associated with overexpression of the ERBB2 oncogene. AR signaling effects on breast cancer progression may depend on ERα and ERBB2 status. Up to 30% of human breast cancers are driven by overactive ERBB2 signaling and it is not clear whether AR expression affects any steps of tumor progression in this cohort of patients. To test this, we generated mammary specific Ar depleted mice (MARKO) by combining the floxed allele of Ar with the MMTV-cre transgene on an MMTV-NeuNT background and compared them to littermate MMTV-NeuNT, Ar(fl)/+ control females. Heterozygous MARKO females displayed reduced levels of AR in mammary glands with mosaic AR expression in ductal epithelium. The loss of AR dramatically accelerated the onset of MMTV-NeuNT tumors in female MARKO mice. In this report we show that accelerated MMTV-NeuNT-dependent tumorigenesis is due specifically to the loss of AR, as hormonal levels, estrogen and progesterone receptors expression, and MMTV-NeuNT expression were similar between MARKO and control groups. MMTV-NeuNT induced tumors in both cohorts displayed distinct loss of AR in addition to ERα, PR, and the pioneer factor FOXA1. Erbb3 mRNA levels were significantly elevated in tumors in comparison to normal mammary glands. Thus the loss of AR in mouse mammary epithelium accelerates malignant transformation rather than the rate of tumorigenesis. |
| first_indexed | 2024-12-11T19:33:21Z |
| format | Article |
| id | doaj.art-d0a0db5dff3b4aa4804805d467b26013 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-11T19:33:21Z |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-d0a0db5dff3b4aa4804805d467b260132022-12-22T00:53:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0184e6045510.1371/journal.pone.0060455Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.Myles C HodgsonGarrett VanostranSarah AlghamdiRobert J PoppitiAlexander I AgoulnikIrina U AgoulnikAndrogen receptor (AR) is commonly expressed in both the epithelium of normal mammary glands and in breast cancers. AR expression in breast cancers is independent of estrogen receptor alpha (ERα) status and is frequently associated with overexpression of the ERBB2 oncogene. AR signaling effects on breast cancer progression may depend on ERα and ERBB2 status. Up to 30% of human breast cancers are driven by overactive ERBB2 signaling and it is not clear whether AR expression affects any steps of tumor progression in this cohort of patients. To test this, we generated mammary specific Ar depleted mice (MARKO) by combining the floxed allele of Ar with the MMTV-cre transgene on an MMTV-NeuNT background and compared them to littermate MMTV-NeuNT, Ar(fl)/+ control females. Heterozygous MARKO females displayed reduced levels of AR in mammary glands with mosaic AR expression in ductal epithelium. The loss of AR dramatically accelerated the onset of MMTV-NeuNT tumors in female MARKO mice. In this report we show that accelerated MMTV-NeuNT-dependent tumorigenesis is due specifically to the loss of AR, as hormonal levels, estrogen and progesterone receptors expression, and MMTV-NeuNT expression were similar between MARKO and control groups. MMTV-NeuNT induced tumors in both cohorts displayed distinct loss of AR in addition to ERα, PR, and the pioneer factor FOXA1. Erbb3 mRNA levels were significantly elevated in tumors in comparison to normal mammary glands. Thus the loss of AR in mouse mammary epithelium accelerates malignant transformation rather than the rate of tumorigenesis.http://europepmc.org/articles/PMC3620158?pdf=render |
| spellingShingle | Myles C Hodgson Garrett Vanostran Sarah Alghamdi Robert J Poppiti Alexander I Agoulnik Irina U Agoulnik Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice. PLoS ONE |
| title | Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice. |
| title_full | Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice. |
| title_fullStr | Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice. |
| title_full_unstemmed | Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice. |
| title_short | Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice. |
| title_sort | reduced androgen receptor expression accelerates the onset of erbb2 induced breast tumors in female mice |
| url | http://europepmc.org/articles/PMC3620158?pdf=render |
| work_keys_str_mv | AT myleschodgson reducedandrogenreceptorexpressionacceleratestheonsetoferbb2inducedbreasttumorsinfemalemice AT garrettvanostran reducedandrogenreceptorexpressionacceleratestheonsetoferbb2inducedbreasttumorsinfemalemice AT sarahalghamdi reducedandrogenreceptorexpressionacceleratestheonsetoferbb2inducedbreasttumorsinfemalemice AT robertjpoppiti reducedandrogenreceptorexpressionacceleratestheonsetoferbb2inducedbreasttumorsinfemalemice AT alexanderiagoulnik reducedandrogenreceptorexpressionacceleratestheonsetoferbb2inducedbreasttumorsinfemalemice AT irinauagoulnik reducedandrogenreceptorexpressionacceleratestheonsetoferbb2inducedbreasttumorsinfemalemice |